Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  229.78
+0.67 (0.29%)
AAPL  279.21
-1.49 (-0.53%)
AMD  218.93
+2.95 (1.37%)
BAC  54.23
+0.34 (0.64%)
GOOG  320.97
+2.58 (0.81%)
META  672.52
+11.00 (1.66%)
MSFT  481.42
+0.58 (0.12%)
NVDA  181.79
-1.59 (-0.87%)
ORCL  216.02
+1.69 (0.79%)
TSLA  454.86
+0.33 (0.07%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.